Elutia/$ELUT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Elutia
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Ticker
$ELUT
Sector
Primary listing
Employees
51
Headquarters
Website
Elutia Metrics
BasicAdvanced
$47M
-
-$0.99
0.62
-
Price and volume
Market cap
$47M
Beta
0.62
52-week high
$3.46
52-week low
$0.50
Average daily volume
272K
Financial strength
Current ratio
0.445
Quick ratio
0.2
Long term debt to equity
-54.458
Total debt to equity
-66.349
Interest coverage (TTM)
-5.70%
Profitability
EBITDA (TTM)
-19.168
Gross margin (TTM)
45.97%
Net profit margin (TTM)
-121.73%
Operating margin (TTM)
-104.42%
Effective tax rate (TTM)
-0.10%
Revenue per employee (TTM)
$430,000
Management effectiveness
Return on assets (TTM)
-36.48%
Return on equity (TTM)
60.13%
Valuation
Price to revenue (TTM)
1.977
Price to book
-1.06
Price to tangible book (TTM)
-1.01
Price to free cash flow (TTM)
-1.289
Free cash flow yield (TTM)
-77.61%
Free cash flow per share (TTM)
-0.846
Growth
Revenue change (TTM)
24.08%
Earnings per share change (TTM)
-52.03%
3-year revenue growth (CAGR)
-8.21%
3-year earnings per share growth (CAGR)
-29.30%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Elutia stock?
Elutia (ELUT) has a market cap of $47M as of February 26, 2026.
What is the P/E ratio for Elutia stock?
The price to earnings (P/E) ratio for Elutia (ELUT) stock is 0 as of February 26, 2026.
Does Elutia stock pay dividends?
No, Elutia (ELUT) stock does not pay dividends to its shareholders as of February 26, 2026.
When is the next Elutia dividend payment date?
Elutia (ELUT) stock does not pay dividends to its shareholders.
What is the beta indicator for Elutia?
Elutia (ELUT) has a beta rating of 0.62. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.